Skip to content
Home › 13F recaps › Q3 2026 › GH

Which funds bought or sold GH in Q3 2026?

Guardant Health Inc. 6 funds bought, 9 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$249M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold GH, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (6)

FundChangeEst. $Now
T. Rowe Price
Asset manager
Added+8233.1%+$263M$267M
D. E. Shaw
Quant & multi-strategy
Added+96.5%+$216M$440M
QRT
Quant & multi-strategy
Added+736%+$205M$233M
Citadel
Quant & multi-strategy
Added+78.8%+$204M$462M
ARK
Growth / crossover
Added+19.9%+$18M$108M
Temasek
Sovereign & pension
Added+3.3%+$6M$189M

Sold (9)

FundChangeEst. $Now
Jane Street
Quant & multi-strategy
Trimmed-91%−$289M$29M
Invesco
Asset manager
Trimmed-32.9%−$260M$530M
Baillie Gifford
Growth / crossover
Trimmed-24.8%−$101M$306M
AllianceBernstein
Asset manager
Trimmed-40.4%−$101M$148M
Susquehanna
Quant & multi-strategy
Trimmed-66.1%−$76M$39M
Jennison
Growth / crossover
Trimmed-76.2%−$48M$15M
Brown Advisory
Asset manager
Trimmed-18.1%−$14M$65M
Farallon
Hedge fund
Trimmed-13.2%−$8M$50M
Polen
Growth / crossover
Trimmed-84.7%−$5M$939K

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.